Tumor cell-intrinsic RIG-I signaling governs synergistic effects of immunogenic cancer therapies and checkpoint inhibitors in mice


Poeck, H., Wintges, A., Dahl, S., Bassermann, F., Haas, T., Heidegger, S. (2021). Eur J Immunol 51, 1531-1534.

DOI:10.1002/eji.202049158(link is external)